Big Pharma BMS rolls out company-wide Anthropic AI policy across drug R&D and trials
Scobleizer · x · 2026-10-14
Bristol Myers Squibb has a company-wide Anthropic policy spanning research, clinical development and manufacturing. Concrete uses: Tempus AI to help design clinical trials, Accenture Workbench to cut trial timelines, Immunai to identify differential drug responses and biomarkers in patient immune systems, and Chai AI to optimise drug candidates. A signal that large pharma is embedding AI across its core pipeline.
More from Companies & People
- Apple and OpenAI face off in first hearing of AI trade secret lawsuit — rohanpaul_ai · 2026-10-14
- Remote gig: Japanese SEO/GEO content editor, ~¥3 per character — daluoseo · 2026-10-14
- Gary Marcus to speak on AI reliability, control and safety at Bloomberg New Economy Forum — GaryMarcus · 2026-10-14
- Apple Zurich is hiring a research intern for multimodal pretraining and scaling laws — CSProfKGD · 2026-10-14
- OpenAI's Codex Ambassadors gathered ~2,500 builders across 52 cities to celebrate GPT-6 Astra launch — paw_lean · 2026-10-14
- Community poll ranks Runway as the world's "highest taste" company, beating Apple and A24 — tlakomy · 2026-10-14